1-2028259-C-T
Variant summary
Our verdict is Benign. Variant got -14 ACMG points: 2P and 16B. PM5BP4_StrongBP6_Very_StrongBS2
The NM_000815.5(GABRD):c.658C>T(p.Arg220Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00135 in 1,612,086 control chromosomes in the GnomAD database, including 4 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R220H) has been classified as Likely benign.
Frequency
Consequence
NM_000815.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -14 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GABRD | NM_000815.5 | c.658C>T | p.Arg220Cys | missense_variant | 6/9 | ENST00000378585.7 | NP_000806.2 | |
GABRD | XM_017000936.2 | c.1363C>T | p.Arg455Cys | missense_variant | 5/8 | XP_016856425.1 | ||
GABRD | XM_011541194.4 | c.697C>T | p.Arg233Cys | missense_variant | 6/9 | XP_011539496.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GABRD | ENST00000378585.7 | c.658C>T | p.Arg220Cys | missense_variant | 6/9 | 1 | NM_000815.5 | ENSP00000367848.4 |
Frequencies
GnomAD3 genomes AF: 0.000802 AC: 122AN: 152118Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000934 AC: 232AN: 248518Hom.: 0 AF XY: 0.000926 AC XY: 125AN XY: 135012
GnomAD4 exome AF: 0.00141 AC: 2057AN: 1459850Hom.: 4 Cov.: 32 AF XY: 0.00143 AC XY: 1035AN XY: 726200
GnomAD4 genome AF: 0.000808 AC: 123AN: 152236Hom.: 0 Cov.: 32 AF XY: 0.000887 AC XY: 66AN XY: 74444
ClinVar
Submissions by phenotype
not provided Benign:2
Likely benign, criteria provided, single submitter | clinical testing | Athena Diagnostics | Jan 09, 2019 | - - |
Benign, criteria provided, single submitter | clinical testing | ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories | Sep 15, 2023 | - - |
GABRD-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | May 28, 2024 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Idiopathic generalized epilepsy Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Nov 11, 2023 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at